Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MultiplexDX International logo — Eliminating cancer misdiagnosis by launching a new diagnosti...

MultiplexDX International

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house.

Founded 2015 United States Rockville, United States 37 employees Grant Total: $1.20M Biotechnology, Health Care +1

General Information

Company Name MultiplexDX International
Founded Year 2015
Location United States Rockville, United States +2
Employees 37
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

Get notified when MultiplexDX International moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MultiplexDX International

MultiplexDX Inc. is an international corporation established in 2015 with units in both Maryland, US, and Slovakia. The company's slogan is "Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house." MultiplexDX aims to achieve this by introducing a 98% accurate, quantitative, and accessible diagnostic test to eliminate cancer misdiagnosis. Additionally, the company operates a boutique oligohouse offering highly specialized custom oligonucleotides to the research community. The mission of MultiplexDX is to transform breast cancer treatment non-responders into responders, ensuring durable responses and aiming to drastically increase survival rates by at least 50%. This ambitious mission is supported by several objectives, including the development of technologies and products for molecular diagnostic markets superior to currently available products, core facility services using proprietary Multiplex TM technology, and the development of hi-tech 3D digital pathology services. The company's last investment was a grant investment received on 24 September 2019 from IPA4SME. MultiplexDX operates in the biotechnology and pharmaceutical industries and is headquartered in the United States. For more information about MultiplexDX, you can visit their official website and follow them on social media: - Website: www.multiplexdx.com - Facebook: MultiplexDX on Facebook - Twitter: MultiplexDX on Twitter - Google Plus: MultiplexDX on Google Plus - YouTube: MultiplexDX on YouTube

Taxonomy: biotech diagnostics, cancer diagnostics, molecular diagnostic tests, oligonucleotides, breast cancer treatment, quantitative diagnostic tests, 3D digital pathology services, molecular biology, histopathological methods, visualization technology, medical diagnostics, prognostic methods, oncology, technology development, medical research

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 24 Sep 2019
Venture Round •••••• 3
Investor
•••• •••• 		04 Oct 2018
Venture Round •••••• 1
Investor
28 Oct 2016
Seed Round •••••• 1
Investor
01 Feb 2016

MultiplexDX International Alternatives & Competitors

MultiplexDX International vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology
Compare MultiplexDX International vs Amadix
MultiplexDX International vs
CSI Laboratories
CSI Laboratories United States

A cancer diagnostics laboratory experienced in helping pathologists and oncologists diagnose and tre...

148 employees
Health Care, Health and Wellness
Compare MultiplexDX International vs CSI Laboratories
MultiplexDX International vs
Metamark Genetics
Metamark Genetics United States

Metamark - A leader in comprehensive urology cancer care

Growth
23 employees
Biotechnology, Health Care
Compare MultiplexDX International vs Metamark Genetics

FAQ About MultiplexDX International

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house.
MultiplexDX International was founded in 2015.
MultiplexDX International is headquartered in Rockville, United States.
MultiplexDX International operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
MultiplexDX International has approximately 37 employees.
MultiplexDX International has completed 4 funding rounds, raising a total of $1.20M. The latest funding stage is Grant.
Top alternatives and competitors to MultiplexDX International include Amadix, CSI Laboratories, Metamark Genetics, LungLife AI, Acu-MDX Laboratory & Research Center Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MultiplexDX International and Amadix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MultiplexDX International and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy